A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects.
Clinical trial NCT05191563 · COMPLETED
Trial details
- NCT number
- NCT05191563
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-31
- Primary completion
- 2021-09-12
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.